Treasury bond yields, including the 10-year note, have risen again after a recent sharp decline, with the 10-year yield reaching 5.31% before settling at 5.14%. This increase in yields means borrowing costs are higher, which has started to attract investors back to the $32 trillion Treasury market seeking better returns. The market is closely watching Treasury financing plans, led by Scott Bessent, for any moves to reduce these borrowing costs. Higher yields reflect changing investor demand and impact government borrowing expenses.
Treasury bond yields have risen to 5.31% before settling at 5.14%, highlighting increased borrowing costs. For readers following Treasury financing plans, here is Pluang's market snapshot as of Oct 20, 2026 02:01 WIB: out of 150 priced US stocks tradable on Pluang, 60 rose and 90 fell today. Notable movers include TSLA at USD 368.85 with a 3.98% gain and a Pluang order activity split of 49% Sell / 51% Buy, MRNA at USD 226.31 up 3.81% with 34% Sell / 66% Buy, and ZM at USD 97.55 rising 3.57% but with 100% Sell orders. Typical hold times range from 59 to 92 days.
The Canadian Investment Regulatory Organization (CIRO) has temporarily halted trading of all shares of Bighorn Metals Corp. (symbol HRNY) as of 1:10 PM ET on October 19, 2026. The halt is pending further information from the company and aims to maint...
The HCA Healthcare Foundation awarded $25,000 to Waypoint (formerly Virginia Home for Boys and Girls) to expand its network of adults trained to support youth mental wellness across Virginia. This funding supports Waypoint's Therapeutic Resources tea...
Angle Advisors has appointed Chris Gessner as a Managing Director, bringing over 20 years of experience in corporate finance, including lending, private equity, and M&A advisory. Gessner's background spans various transaction types and industries suc...
The FDA has approved Jemperli (dostarlimab) as the first immunotherapy for adults with stage II and III MSI-H/dMMR locally advanced rectal cancer. This approval is based on the AZUR-1 trial showing 68% of patients achieved complete clinical response ...
Ethereum-based crypto Pepeto is in its final presale stages ahead of a Binance listing, with rapid investor interest driving record presale speed. Pepeto addresses issues Cardano aimed to fix, such as high fees and network congestion, offering zero-f...
